Navigation Links
Perforomist Inhalation Solution data to be presented at American Thoracic Society conference
Date:5/14/2009

Napa, Calif., (May 14, 2009) Dey, L.P., a subsidiary of Mylan Inc. (NYSE: MYL), announced today that data from two presentations highlighting the use of Perforomist (formoterol fumarate) Inhalation Solution will be featured in poster format at the International Conference of the American Thoracic Society on May 19, 2009 in San Diego.

In one analysis, use of Perforomist Inhalation Solution, when added to maintenance tiotropium, resulted in improved pulmonary function, dyspnea (shortness of breath) and rescue medication use versus treatment with tiotropium alone. In a second study, patient satisfaction increased in those treated with Perforomist Inhalation Solution twice daily compared with ipratropium/albuterol metered-dose inhaler (MDI) four times daily.

Presentation Details:

In COPD, Adding Nebulized Formoterol to Tiotropium Treatment Provides Added Benefits in Pulmonary Function, Dyspnea, and Rescue Medication Use: A Pooled Analysis; poster board # J51

Date: Tuesday, May 19, 2009
Poster viewing: 10:30 a.m. to 12:45 p.m. PT
Location: Area J (Sails Pavilion, Upper Level), San Diego Convention Center

Nebulized Formoterol Improved Efficacy and Increased Patient Satisfaction Compared with Ipratropium/Albuterol MDI; poster board # J50

Date: Tuesday, May 19, 2009
Poster viewing: 10:30 a.m. to 12:45 p.m. PT
Location: Area J (Sails Pavilion, Upper Level), San Diego Convention Center

About COPD

COPD is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual patients. Its pulmonary component is characterized by airflow limitation that is not fully reversible. The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lung to noxious particles or gases.

COPD is the fourth leading cause of death in America, behind heart disease,
'/>"/>

Contact: Julie Piszczor
jpiszczor@powelltate.com
202-585-2106
Powell Tate
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Dey, L.P. Highlights Perforomist(R) Inhalation Solution Data to Be Presented at the International Conference of the American Thoracic Society
2. U.S. Patent and Trademark Office Issues Mylans Specialty Division, Dey L.P., Three Additional Patents Protecting Perforomist(R) Inhalation Solution
3. Concomitant use of Perforomist & tiotropium -- significant improvements -- COPD
4. Perforomist-comparable pharmacokinetic and pharmacodynamic profile to DPI formulation
5. Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008
6. Par Pharmaceutical Begins Shipment of Budesonide Inhalation Suspension Immediately
7. FDA Approves ASMANEX (R) TWISTHALER(R) (Mometasone Furoate Inhalation Powder) for the Once Daily Maintenance Treatment of Asthma in Children Ages 4-11
8. Employers Make New Commitments to Back-Up Child and Elder Care Solutions with Bright Horizons
9. Management Health Solutions, Inc. Offers Free Data Cleansing
10. LightLab Imaging Introduces Worlds Highest Resolution OCT System for Intracoronary Imaging at EuroPCR 2009
11. Statement by American Dental Association President John S. Findley on Passage of H.Res. 204, a Congressional Resolution Congratulating the Association for its 150 Years of Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... A newly released article from ... the influenza virus that will soon be spreading across the ... article begins with a brief explanation of what the influenza ... families that children under the age of 5, adults over ... such as heart and lung diseases, asthma, or diabetes, are ...
(Date:11/28/2014)... Georgia (PRWEB) November 28, 2014 Patten ... and locally grown. With those passions driving them, they've ... Georgia Grown. Having tried other pecans oils, they've found ... Pitts, Georgia to be exceptionally flavorful, retaining the buttery ... The same nutritional benefits found in pecans ...
(Date:11/28/2014)... Schools like Centra Rivermont understand the therapeutic and ... to its students. That is why the Virginia ... structure at its mental health services facility in ... for children who are identified as needing additional ... served the needs of children with severe emotional ...
(Date:11/28/2014)... talklocal ( http://www.talklocal.com ) is launching in ... by phone in about 90 seconds. , The launch ... reported to have touched down just north of the city ... tornadoes, Denver residents now know all too well the value ... having local pros in over 50 service categories on speed ...
(Date:11/28/2014)... 2014 Nipomo Family Dentistry , ... recently opened its doors at 195 N. Thompson St., ... preventative care like teeth cleanings, oral exams, fillings, implants ... teeth whitening (and Kor whitening), laser whitening, gum tissue ... Family Dentistry’s five-person team also takes a philanthropic approach ...
Breaking Medicine News(10 mins):Health News:How Flu Vaccines Can Impact Families Is Discussed in New Article from Community Health Center of Snohomish County 2Health News:Patten Pecans Goes Local with Nutritious Georgia Pecan Oil 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 3Health News:TalkLocal Launches In Denver A Week After Multiple Tornadoes Hit Near City 2Health News:Nipomo Family Dentistry Opens New Dental Office in Nipomo 2Health News:Nipomo Family Dentistry Opens New Dental Office in Nipomo 3
... 1 Oral Session and 21 Poster Sessions ... Debuts New Clostridium difficile Program , LOUISVILLE, Colo., ... today that it will be presenting 21 posters,highlighting three ... Antimicrobial Agents and Chemotherapy (ICAAC) held at the,McCormick Place ...
... Centers to Offer Free Health Assessments, HARRISBURG, Pa., ... invited Pennsylvanians to take advantage of,free health assessments being ... Sept. 21. The free health services are available in,conjunction ... which is observed on,Sept. 18., "Nearly 800,000 Pennsylvanians ...
... to Lead Financing Strategies to Fund Growth, ... Bulletin Board: APHY) today announced that it has ... EFH ) to develop and,lead financing strategies. Assured ... for patients with chronic pain and other,long-term care ...
... strengthen brand recognition, national ... BUFFALO, N.Y., Sept. 17 Meritain Health, ... today announced,the name change of recently acquired benefits ... of Meritain Health. Meritain Health acquired Weyco ...
... 17 LifeNet Health, a leading,biomedical and allograft ... Wound Allograft Institute" in affiliation with The Living ... and most progressive,organ and tissue recovery organizations in ... Institute" will directly serve the needs of burn,patients ...
... asthma type, study concludes, , , MONDAY, Sept. 17 ... the type of asthma you develop, new research ... in affluent, developed countries had more allergy-triggered asthma ... countries. , "The link between atopic sensitization ...
Cached Medicine News:Health News:Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2Health News:Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 3Health News:Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 4Health News:Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 5Health News:Assured Pharmacy Retains Empire Financial Group 2Health News:Assured Pharmacy Retains Empire Financial Group 3Health News:Meritain Health Announces Name Change for Acquired Companies 2Health News:LifeNet Health Establishes 'The Skin & Wound Allograft Institute' 2Health News:Allergy-Induced Asthma More Common in Affluent Countries 2Health News:Allergy-Induced Asthma More Common in Affluent Countries 3
(Date:11/26/2014)... 2014 Investor-Edge has initiated coverage on ... Horizon Pharma PLC (NASDAQ: HZNP ), Endocyte Inc. ... JNJ ), and Theravance Inc. (NASDAQ: THRX ... at: http://investor-edge.com/register . On Tuesday, November 25, ... Dow Jones Industrial Average edged 0.02% lower, to finish the ...
(Date:11/26/2014)... Pa. , Nov. 26, 2014 ... to the development of innovative transdermal synthetic cannabinoid treatments, ... Piper Jaffray 26th Annual Healthcare Conference 2014. The conference ... New York Palace in New York ... will present at 4:50 pm on Tuesday, December 2. ...
(Date:11/26/2014)... and LONDON , Nov. ... market intelligence, MarketResearch.com is pleased to announce the distribution ... Consultancy focusing on the active pharmaceutical ingredient (API) market. ... http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . In IQ4I,s newest ... Forecast to 2020 , IQ4I analysts ...
Breaking Medicine Technology:Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3
... Biotechnology Company updates progress and upcoming,milestones on ... 2007 /PRNewswire-FirstCall/ - SemBioSys,Genetics Inc. , a ... for metabolic and cardiovascular disease,today announced positive ... human insulin. The Company,presented its findings at ...
... Tolerability Profile,in Subjects with Type 2 Diabetes ... /PRNewswire-FirstCall/ -- Phase III data,presented this week ... Diabetes,Association demonstrated that saxagliptin, an inhibitor of,dipeptidyl-peptidase-4 ... BMY) and AstraZeneca (NYSE: AZN), in,combination with ...
Cached Medicine Technology:SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 2SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 3SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6
... Gellhorn Pessary is used for ... prolapse, or procidentia. It has ... and comes in nine sizes. ... easily folds over for insertion, ...
... are among the smallest and ... with advanced reporting software that ... information. Extensive testing by independent ... accuracy, making it widely recognized ...
Low Profile Design for Precise Anchor Placement...
... is a minimally invasive treatment option ... urinary incontinence (SUI). The Monarc treats ... abdominal stress events, such as sneezing, ... approach avoids the retropubic space.Monarc's transobturator ...
Medicine Products: